Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| Our focus on productivity continues to drive sustainable value for the enterprise, while creating more streamlined processes better experiences for our members, patients and provider partners and driving best-in-class quality and customer service results |
| We have continued to see favorable net investment income, as you've seen in our results |
| And you still feel confident that more broadly, we should be well positioned such that we should be able to continue to generate membership growth at or above the industry rate |
| Results for the quarter include outperformance in our Medicaid and primary care businesses |
| Turning to Medicaid; the business exceeded expectations in the quarter, primarily driven by favorable membership due to redetermination timing which continue to track slightly favorable to our expectations, combined with disciplined medical cost management initiatives and lower-than-expected utilization |
| Moving now to CenterWell; the segment continued its solid performance seen throughout the year, outperforming expectations in the quarter |
| In addition, we are pleased to raise our guidance for full year individual MA membership growth by an additional 35,000 members to $860,000 driven by continued higher-than-expected new sales |
| As we said, the outsized membership growth and the progression you will typically see in the margin profile of those new member cohorts improves over time |
| As we've shared previously, our ability to deliver on our targeted earnings growth rate in 2023, while also achieving this impressive membership growth is supported by the strength and scale of our organization |
| underpinned by a continued focus on disciplined investments, driving sustainable productivity improvements and delivering consistent fundamentals, including industry-leading Stars results and higher customer satisfaction as reflected in our net promote receivers |
| Further, our strong membership growth creates significant momentum as we advance towards our 2025 adjusted EPS target of $37 |
| And that, again, is a durable advantage for us where we do know some others will have some challenges to deal with there while others may have some improvement |
| We are very pleased, though, again, have the really strong Stars results that were published recently |
| Today historically [indiscernible] although we're seeing more and more of a more sophisticated with providers to take risk on [indiscernible] and difference in the months to see better financial results, including lower MLRs and higher contribution to MTN |
| Obviously, we have strong penetration in HMO products and some of our [indiscernible] and highly risk-insured markets |
| All in, we expect our balanced approach to our 2024 product strategy positions us well and we anticipate 2024 individual MA membership growth to be at or above the overall industry growth rate |
| Our product enhancements are coupled with Humana's leading position in quality and experience |
| Mana continues to deliver exceptional quality to our members as levered by our CMS star ratings |
| To your point, the higher enrollment growth, particularly the Asian component of that which we have seen a nice uptick in market share there |
| We continue to see better-than-expected patient growth, adding over 17,000 patients or nearly 89% growth in our de novo centers since December 31, plus 15,000 patients in our wholly owned centers, representing 9% growth year-to-date |
| And in addition, we continue to see good results from our agnostic channel |
| We continue to see really strong results there and probably they're overachieving from our budget |
| And we're proud that Humana once again has been named the best overall Medicare Advantage insurance company by U.S |
| Additionally, Humana ranked as the best company for member experience and was declared the best company for low premium plant availability |
| Our performance to date continues to reflect the strength and agility of the enterprise, demonstrating our ability to successfully navigate the higher-than-anticipated utilization while delivering on our earnings commitment and driving individual Medicare Advantage membership growth that significantly outpaces the industry |
| Results in the quarter were slightly positive -- slightly above initial expectations driven by outperformance in our Medicaid and primary care businesses and continued focus on driving sustainable productivity gains, offset by modestly higher-than-anticipated utilization in our Medicare Advantage business |
| Our goal is to deliver best-in-class agent and customer experience and have made investments in AI power tools and tallied infrastructure to reduce consumer hold times and transfers |
| Finally, we are excited about the strong growth of our internal payer agnostic channel which is expected to double its sales production year-over-year this AAAP [ph] |
| Our primary care organization results exceeded expectations, driven by better-than-expected patient volume and revenue combined with lower-than-anticipated utilization, resulting in improved medical margin in our fully own centers |
| Managed fundamentals are strong and we remain committed to leveraging the strength and scale of our enterprise navigate near-term challenges while continuing to advance our strategy |
| Statement |
|---|
| We currently expect a net decline of approximately 750,000 TEP members in 2024, including a loss of approximately 220,000 members as a result of exceeding the low income benchmark |
| Just given the PDP losses, some of the pressures that we're hearing about both in the home health and the physician business |
| Broadly speaking, 2024 competitor plan design reflect less benefit degradation than anticipated which will likely lead to fewer consumers shopping and therefore, less opportunity for Humana to meaningfully outpace the industry growth rate |
| The CenterWell pharmacy is going to be impacted by the MA growth as well as the decline in PDP growth |
| does put some pressure on MLRs |
| I know last year, at this time, you gave very precise enrollment growth guidance and perhaps that was because of the shortfall in the '22 enrollment |
| So some of the losses in '24 will be disproportionately low income because of exceeding the benchmark |
| And in result, when they're shopping more, though, we've seen increased attrition |
| We're seeing more pressure in our LTPO offerings versus our HMO |
| We have started to see COVID start to decline is coming down |
| So we are anticipating a headwind in '24 |
| Those did represent a headwind to us, recognizing that we won't be able to have as much impact as we have historically from those efforts and we did account for that in the bid |
| So you've got utilization being a little higher but you've also got the drag of all these new members |
| We shared previously that the middleware penetration rates for those populations and the PDP does run significantly lower than the M&A book |
| With respect to seeing along PDP, the overall PDP market continues to decline as Medicare beneficiaries select Medicare Advantage over original Medicare and PDP -- in addition, we remain disciplined in the pricing of our PDP products as cost trends continue to rise |
| Sarah James So the hospitals this quarter have pretty consistently been talking about pressure on the claims review process for physician fees, especially in the ED and the difference between inpatient versus monitoring |
| obviously, for 2024, the industry is absorbing the more negative rate environment |
| As a result, our Walmart Value plan will not be as competitively priced as it has been historically and our basic plan will exceed the low income benchmark in 16 regions in 2024 |
| You do talk about benefit design change as impacting MLR and certainly, some of that was intentional and we knew that coming into the year or benefit investments |
| And Lisa, as respect to the $37, I would say, in general, as we've commented, we have been anticipating that the rate environment would not continue to be as favorable as we've seen in the last number of years |
Please consider a small donation if you think this website provides you with relevant information